These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25538562)

  • 1. Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats.
    Diederich K; Schmidt A; Beuker C; Strecker JK; Wagner DC; Boltze J; Schäbitz WR; Minnerup J
    Front Cell Neurosci; 2014; 8():411. PubMed ID: 25538562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow cell transplantation time-dependently abolishes efficacy of granulocyte colony-stimulating factor after stroke in hypertensive rats.
    Pösel C; Scheibe J; Kranz A; Bothe V; Quente E; Fröhlich W; Lange F; Schäbitz WR; Minnerup J; Boltze J; Wagner DC
    Stroke; 2014 Aug; 45(8):2431-7. PubMed ID: 24984745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor and bone marrow mononuclear cells for stroke treatment in the aged brain.
    Buga AM; Scheibe J; Moller K; Ciobanu O; Posel C; Boltze J; Popa-Wagner A
    Curr Neurovasc Res; 2015; 12(2):155-62. PubMed ID: 25760217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
    Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
    Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats.
    Minnerup J; Wagner DC; Strecker JK; Pösel C; Sevimli-Abdis S; Schmidt A; Schilling M; Boltze J; Diederich K; Schäbitz WR
    Front Cell Neurosci; 2014; 7():288. PubMed ID: 24409120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone.
    Balseanu AT; Buga AM; Catalin B; Wagner DC; Boltze J; Zagrean AM; Reymann K; Schaebitz W; Popa-Wagner A
    Front Aging Neurosci; 2014; 6():130. PubMed ID: 25002846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia.
    Gu Y; Guo L; Guo J; Dardik A; Zhang S; Tong Z; Zhang J; Wang Z
    Int Angiol; 2017 Aug; 36(4):346-353. PubMed ID: 27958690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial.
    Moniche F; Montaner J; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Cayuela A; Escudero I; de la Torre-Laviana FJ; Boada C; Rosell A; Mayol A; Jimenez MD; Gil-Peralta A; Gonzalez A
    Cell Transplant; 2014; 23 Suppl 1():S57-64. PubMed ID: 25335778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two versus three day upfront use of granulocyte-colony stimulating factor in healthy bone marrow donors for pediatric bone marrow transplantation.
    Aksu T; Ok Bozkaya İ; Akpınar Tekgündüz S; Olcar Kanbur M; Köksal Y; Özgüner M; Özbek NY
    Transfus Apher Sci; 2017 Dec; 56(6):829-831. PubMed ID: 29153311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.
    Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A
    Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
    Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
    Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
    Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?
    Sandu RE; Balseanu AT; Bogdan C; Slevin M; Petcu E; Popa-Wagner A
    Exp Gerontol; 2017 Aug; 94():73-77. PubMed ID: 28093317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Growth Factor and Bone Marrow Cell Therapy Induces Bleeding and Alters Immune Response After Stroke in Mice.
    Strecker JK; Olk J; Hoppen M; Gess B; Diederich K; Schmidt A; Schäbitz WR; Schilling M; Minnerup J
    Stroke; 2016 Mar; 47(3):852-62. PubMed ID: 26839353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection.
    Luo J; Zhang HT; Jiang XD; Xue S; Ke YQ
    Acta Neurochir (Wien); 2009 Nov; 151(11):1483-92. PubMed ID: 19499175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis induced by autologous whole bone marrow stem cells transplantation.
    Lee KB; Kim AK; Kim MJ; Do YS; Shin SW; Kim JS; Park CJ; Kang KS; Kim BS; Joh JH; Oh WI; Hong HK; Kim DI
    Int J Stem Cells; 2008 Nov; 1(1):64-9. PubMed ID: 24855510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful regeneration after experimental stroke by granulocyte-colony stimulating factor is not further enhanced by constraint-induced movement therapy either in concurrent or in sequential combination therapy.
    Diederich K; Quennet V; Bauer H; Müller HD; Wersching H; Schäbitz WR; Minnerup J; Sommer C
    Stroke; 2012 Jan; 43(1):185-92. PubMed ID: 22020031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of stem cell factor and granulocyte-colony stimulating factor in brain repair during chronic stroke.
    Piao CS; Gonzalez-Toledo ME; Xue YQ; Duan WM; Terao S; Granger DN; Kelley RE; Zhao LR
    J Cereb Blood Flow Metab; 2009 Apr; 29(4):759-70. PubMed ID: 19209180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of age on the efficacy of bone marrow mononuclear cell transplantation in experimental stroke.
    Wagner DC; Bojko M; Peters M; Lorenz M; Voigt C; Kaminski A; Hasenclever D; Scholz M; Kranz A; Weise G; Boltze J
    Exp Transl Stroke Med; 2012 Aug; 4(1):17. PubMed ID: 22920434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.